全文获取类型
收费全文 | 175篇 |
免费 | 9篇 |
国内免费 | 1篇 |
出版年
2022年 | 2篇 |
2021年 | 2篇 |
2016年 | 4篇 |
2015年 | 5篇 |
2014年 | 4篇 |
2013年 | 7篇 |
2012年 | 14篇 |
2011年 | 16篇 |
2010年 | 5篇 |
2009年 | 4篇 |
2008年 | 3篇 |
2007年 | 7篇 |
2006年 | 2篇 |
2005年 | 4篇 |
2004年 | 5篇 |
2003年 | 10篇 |
2002年 | 10篇 |
2001年 | 4篇 |
2000年 | 7篇 |
1999年 | 2篇 |
1994年 | 1篇 |
1992年 | 2篇 |
1990年 | 3篇 |
1988年 | 3篇 |
1984年 | 1篇 |
1982年 | 2篇 |
1977年 | 1篇 |
1976年 | 1篇 |
1974年 | 1篇 |
1972年 | 1篇 |
1965年 | 1篇 |
1964年 | 1篇 |
1963年 | 9篇 |
1962年 | 10篇 |
1961年 | 3篇 |
1959年 | 1篇 |
1958年 | 2篇 |
1956年 | 2篇 |
1955年 | 1篇 |
1951年 | 3篇 |
1950年 | 1篇 |
1944年 | 1篇 |
1943年 | 2篇 |
1942年 | 1篇 |
1941年 | 1篇 |
1940年 | 3篇 |
1937年 | 1篇 |
1936年 | 2篇 |
1935年 | 2篇 |
1932年 | 2篇 |
排序方式: 共有185条查询结果,搜索用时 15 毫秒
21.
Gaál EI Salo P Kristiansson K Rehnström K Kettunen J Sarin AP Niemelä M Jula A Raitakari OT Lehtimäki T Eriksson JG Widen E Günel M Kurki M von und Zu Fraunberg M Jääskeläinen JE Hernesniemi J Järvelin MR Pouta A;International Consortium for Blood Pressure Genome-Wide Association Studies Newton-Cheh C Salomaa V Palotie A Perola M 《PLoS genetics》2012,8(3):e1002563
Although genome-wide association studies (GWAS) have identified hundreds of complex trait loci, the pathomechanisms of most remain elusive. Studying the genetics of risk factors predisposing to disease is an attractive approach to identify targets for functional studies. Intracranial aneurysms (IA) are rupture-prone pouches at cerebral artery branching sites. IA is a complex disease for which GWAS have identified five loci with strong association and a further 14 loci with suggestive association. To decipher potential underlying disease mechanisms, we tested whether there are IA loci that convey their effect through elevating blood pressure (BP), a strong risk factor of IA. We performed a meta-analysis of four population-based Finnish cohorts (n(FIN) = 11 266) not selected for IA, to assess the association of previously identified IA candidate loci (n = 19) with BP. We defined systolic BP (SBP), diastolic BP, mean arterial pressure, and pulse pressure as quantitative outcome variables. The most significant result was further tested for association in the ICBP-GWAS cohort of 200 000 individuals. We found that the suggestive IA locus at 5q23.2 in PRDM6 was significantly associated with SBP in individuals of European descent (p(FIN) = 3.01E-05, p(ICBP-GWAS) = 0.0007, p(ALL) = 8.13E-07). The risk allele of IA was associated with higher SBP. PRDM6 encodes a protein predominantly expressed in vascular smooth muscle cells. Our study connects a complex disease (IA) locus with a common risk factor for the disease (SBP). We hypothesize that common variants in PRDM6 can contribute to altered vascular wall structure, hence increasing SBP and predisposing to IA. True positive associations often fail to reach genome-wide significance in GWAS. Our findings show that analysis of traditional risk factors as intermediate phenotypes is an effective tool for deciphering hidden heritability. Further, we demonstrate that common disease loci identified in a population isolate may bear wider significance. 相似文献
22.
TI Pollin T Isakova KA Jablonski PI de Bakker A Taylor J McAteer Q Pan ES Horton LM Delahanty D Altshuler AR Shuldiner RB Goldberg JC Florez PW Franks;Diabetes Prevention Program Research Group 《PLoS genetics》2012,8(8):e1002895
Weight-loss interventions generally improve lipid profiles and reduce cardiovascular disease risk, but effects are variable and may depend on genetic factors. We performed a genetic association analysis of data from 2,993 participants in the Diabetes Prevention Program to test the hypotheses that a genetic risk score (GRS) based on deleterious alleles at 32 lipid-associated single-nucleotide polymorphisms modifies the effects of lifestyle and/or metformin interventions on lipid levels and nuclear magnetic resonance (NMR) lipoprotein subfraction size and number. Twenty-three loci previously associated with fasting LDL-C, HDL-C, or triglycerides replicated (P = 0.04–1×10−17). Except for total HDL particles (r = −0.03, P = 0.26), all components of the lipid profile correlated with the GRS (partial |r| = 0.07–0.17, P = 5×10−5–1×10−19). The GRS was associated with higher baseline-adjusted 1-year LDL cholesterol levels (β = +0.87, SEE±0.22 mg/dl/allele, P = 8×10−5, P
interaction = 0.02) in the lifestyle intervention group, but not in the placebo (β = +0.20, SEE±0.22 mg/dl/allele, P = 0.35) or metformin (β = −0.03, SEE±0.22 mg/dl/allele, P = 0.90; P
interaction = 0.64) groups. Similarly, a higher GRS predicted a greater number of baseline-adjusted small LDL particles at 1 year in the lifestyle intervention arm (β = +0.30, SEE±0.012 ln nmol/L/allele, P = 0.01, P
interaction = 0.01) but not in the placebo (β = −0.002, SEE±0.008 ln nmol/L/allele, P = 0.74) or metformin (β = +0.013, SEE±0.008 nmol/L/allele, P = 0.12; P
interaction = 0.24) groups. Our findings suggest that a high genetic burden confers an adverse lipid profile and predicts attenuated response in LDL-C levels and small LDL particle number to dietary and physical activity interventions aimed at weight loss. 相似文献
23.
24.
25.
26.
27.
28.
29.
30.